FRES
Fresh2 Group Ltd
NASDAQ: FRES · HEALTHCARE · DIAGNOSTICS & RESEARCH
$0.85
+0.00% today
Updated 2026-04-30
Market cap
$2.97M
P/E ratio
—
P/S ratio
0.12x
EPS (TTM)
$-72.68
Dividend yield
—
52W range
$0 – $0
Volume
0.3M
Fresh2 Group Ltd (FRES) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-699.00%
ROE
-216.20%
ROA
-62.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $10.82M | $-100.79M | 44.24% | -824.85% | -931.86% |
| 2020 | $19.39M | $-76.08M | 62.81% | -454.07% | -392.39% |
| 2021 | $17.75M | $-117.16M | 68.13% | -589.60% | -659.93% |
| 2022 | $12.04M | $-101.89M | 69.21% | -870.20% | -846.01% |